| JAML inhibits colorectal carcinogenesis by modulating the tumor immune microenvironment. | JAML inhibits colorectal carcinogenesis by modulating the tumor immune microenvironment.
Cheng S, Li M, Li C, Dai Y, Zhuo J, Wang J, Qian J, Hao Z. | 05/28/2024 |
| JAML promotes the antitumor role of tumor-resident CD8[+] T cells by facilitating their innate-like function in human lung cancer. | JAML promotes the antitumor role of tumor-resident CD8(+) T cells by facilitating their innate-like function in human lung cancer.
Hao Z, Xin Z, Chen Y, Shao Z, Lin W, Wu W, Lin M, Liu Q, Chen D, Wu D, Wu P. | 05/23/2024 |
| Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma. | Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma.
Wu Q, Wang YB, Che XW, Wang H, Wang W. | 05/19/2023 |
| Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/beta-catenin signaling pathway in lung adenocarcinoma. | Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
Wu Q, Li R, Wang QX, Zhang MY, Liu TT, Qu YQ., Free PMC Article | 06/11/2022 |
| Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma. | Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Fang L, Yu W, Yu G, Zhong F, Ye B., Free PMC Article | 03/19/2022 |
| JAML promotes CD8 and gammadelta T cell antitumor immunity and is a novel target for cancer immunotherapy. | JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy.
McGraw JM, Thelen F, Hampton EN, Bruno NE, Young TS, Havran WL, Witherden DA., Free PMC Article | 12/4/2021 |
| Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism. | Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism.
Fu Y, Sun Y, Wang M, Hou Y, Huang W, Zhou D, Wang Z, Yang S, Tang W, Zhen J, Li Y, Wang X, Liu M, Zhang Y, Wang B, Liu G, Yu X, Sun J, Zhang C, Yi F. | 11/27/2021 |
| Findings suggest that specific JAM family members play an important role in the transendothelial migration (TEM) of in vitro-generated mouse and human dendritic cells (DCs) from the inoculation site to regional lymph nodes (LNs) in DC-based cancer immunotherapy. | Junctional adhesion molecules mediate transendothelial migration of dendritic cell vaccine in cancer immunotherapy.
Roh SE, Jeong Y, Kang MH, Bae YS. | 10/5/2019 |
| Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator) | Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR., Free PMC Article | 06/30/2010 |
| Integrin activation is required for the dissociation of JAM-L-VLA-4 complexes and the accumulation of functional JAM-L dimers, which indicates that the leukocyte integrin VLA-4 controls JAM-L function in cis by controlling its dimerization state. | JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4beta1 integrin activation.
Luissint AC, Lutz PG, Calderwood DA, Couraud PO, Bourdoulous S., Free PMC Article | 01/21/2010 |
| expressed on leukocytes with a possible role in leukocyte transmigration | JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells.
Moog-Lutz C, Cavé-Riant F, Guibal FC, Breau MA, Di Gioia Y, Couraud PO, Cayre YE, Bourdoulous S, Lutz PG. | 01/21/2010 |